SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-020485
Filing Date
2024-03-06
Accepted
2024-03-06 17:00:35
Documents
103
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0200896-10k_oramedph.htm   iXBRL 10-K 1545523
2 AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED P ea0200896ex10-2_oramed.htm EX-10.2 12844
3 AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED ea0200896ex10-3_oramed.htm EX-10.3 8697
4 AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED L ea0200896ex10-5_oramed.htm EX-10.5 8926
5 AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED ea0200896ex10-6_oramed.htm EX-10.6 6234
6 AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED ea0200896ex10-15_oramed.htm EX-10.15 12573
7 AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED ea0200896ex10-16_oramed.htm EX-10.16 8574
8 THIRD AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN O ea0200896ex10-20_oramed.htm EX-10.20 9214
9 FOURTH AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN ea0200896ex10-21_oramed.htm EX-10.21 6886
10 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS ea0200896ex10-22_oramed.htm EX-10.22 86336
11 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea0200896ex23-1_oramed.htm EX-23.1 1943
12 CERTIFICATION ea0200896ex31-1_oramed.htm EX-31.1 9950
13 CERTIFICATION ea0200896ex31-2_oramed.htm EX-31.2 11198
14 CERTIFICATION ea0200896ex32-1_oramed.htm EX-32.1 3398
15 CERTIFICATION ea0200896ex32-2_oramed.htm EX-32.2 3334
16 ORAMED PHARMACEUTICALS INC. CLAWBACK POLICY, ADOPTED NOVEMBER 9, 2023 ea0200896ex97-1_oramed.htm EX-97.1 40896
17 GRAPHIC image_001.jpg GRAPHIC 2132
18 GRAPHIC ex97-1_001.jpg GRAPHIC 2260
  Complete submission text file 0001213900-24-020485.txt   8257559

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE ormp-20231231.xsd EX-101.SCH 85483
20 XBRL CALCULATION FILE ormp-20231231_cal.xml EX-101.CAL 41467
21 XBRL DEFINITION FILE ormp-20231231_def.xml EX-101.DEF 404581
22 XBRL LABEL FILE ormp-20231231_lab.xml EX-101.LAB 699861
23 XBRL PRESENTATION FILE ormp-20231231_pre.xml EX-101.PRE 404965
104 EXTRACTED XBRL INSTANCE DOCUMENT ea0200896-10k_oramedph_htm.xml XML 892981
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35813 | Film No.: 24726812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)